Literature DB >> 22941264

Outcome measures in peripheral neuropathies: requirements through statements.

Ingemar S J Merkies1, Giuseppe Lauria, Catharina G Faber.   

Abstract

PURPOSE OF REVIEW: The aim of this review is to inform and educate clinicians through statements about the most important clinimetric requirements for outcome measures in peripheral neuropathies. RECENT
FINDINGS: The basic needs of an outcome measure (simple, valid, reliable, and responsive) are generally well known by physicians. However, techniques such as the Rasch methodology offer modern additional requirements, particularly in the development of interval-based outcome measures.
SUMMARY: Peripheral neuropathies are chronic disorders that generally cause deficits at the body level (impairments, e.g. weakness and sensory deficit) and may lead to problems in daily life and social functioning with a reduction in quality-of-life expectations. Fundamental steps should be taken in the design of clinical studies in peripheral neuropathies to ameliorate these deficits, of which the choice of a proper outcome measure representing the level of interest is considered a crucial one. However, choosing a proper outcome is not only dependent on the proposed research purpose, but perhaps more importantly, on the fulfilment of the clinimetric needs by the scale of interest. All outcome measures should be rigorously examined to determine their scientific soundness before being generally used. Respecting the basic needs of an outcome measure like being simple, valid, reliable, and responsive, this review will highlight through statements the modern scientific essentials in the design and evaluation of an outcome measure. The Rasch method as a modern vehicle will also be addressed, accentuating the need to shift towards a more modern clinimetric era. The presented findings could be applied to all forms of peripheral neuropathies.

Entities:  

Mesh:

Year:  2012        PMID: 22941264     DOI: 10.1097/WCO.0b013e328357f30f

Source DB:  PubMed          Journal:  Curr Opin Neurol        ISSN: 1350-7540            Impact factor:   5.710


  4 in total

Review 1.  The pathogenesis of multifocal motor neuropathy and an update on current management options.

Authors:  Jean-Marc Léger; Raquel Guimarães-Costa; Ruxandra Iancu Ferfoglia
Journal:  Ther Adv Neurol Disord       Date:  2015-05       Impact factor: 6.570

2.  Rasch model-based testing of the European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire-Chemotherapy-Induced Peripheral Neuropathy (QLQ-CIPN20) using Alliance for Clinical Trials in Oncology (Alliance) A151408 study data.

Authors:  Ellen M Lavoie Smith; Noah Zanville; Grace Kanzawa-Lee; Clare Donohoe; Celia Bridges; Charles Loprinzi; Jennifer Le-Rademacher; James J Yang
Journal:  Support Care Cancer       Date:  2018-11-20       Impact factor: 3.603

3.  The facioscapulohumeral muscular dystrophy Rasch-built overall disability scale (FSHD-RODS).

Authors:  Karlien Mul; Tatiana Hamadeh; Corinne G C Horlings; Rabi Tawil; Jeffrey M Statland; Sabrina Sacconi; Alastair J Corbett; Nicol C Voermans; Catharina G Faber; Baziel G M van Engelen; Ingemar S J Merkies
Journal:  Eur J Neurol       Date:  2021-05-02       Impact factor: 6.089

4.  Addressing the Need of a Translational Approach in Peripheral Neuropathy Research: Morphology Meets Function.

Authors:  Laura Monza; Giulia Fumagalli; Alessia Chiorazzi; Paola Alberti
Journal:  Brain Sci       Date:  2021-01-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.